3 Pharma Stocks That Could Make You Richer in November (and Beyond)
Big drugmakers don't always deliver especially impressive growth. As a result, their stocks sometimes plod along. Many of them pay dividends and make income-seeking investors happy. But growth-oriented investors are often left in the lurch.
That's not always the case, though. We asked three Motley Fool contributors to pick pharma stocks that have solid growth potential. Here's why they think Amgen (NASDAQ: AMGN), Pfizer (NYSE: PFE), and Eli Lilly (NYSE: LLY) could make investors richer in November (and beyond.)
Image source: Getty Images.
Source Fool.com
